Best Open Innovation practice 2024

Last month, on November 7 2024, Florian Montel received the Best Open innovation practice award at the World Open Innovation Conference in Berkeley for its exceptional originality, fostering groundbreaking collaboration between academia and industry to tackle challenges in life sciences.

Join us to discover the case as Florian will present opnMe during this special webinar. Be inspired by the best practice and make use of the opportunity to ask your questions directly to the authors!

CHECK OUT THE REPLAY

WHat is it about?

Open Innovation faces challenges in the life sciences due to complex problem-solving needs and a traditionally secretive culture. This Best Practice addresses these by offering open access to high-quality molecules and tools, fostering collaborations and advancing drug discovery. This opnMe platform connects academia with industry, yielding significant research output and global reach. Despite challenges like contracting complexities, its success demonstrates the potential of Open Innovation when supported by strategic investment and community alignment

Why the Award?

This Best Practice stood out for its exceptional originality, fostering groundbreaking collaboration between academia and industry to tackle challenges in life sciences.

Its innovative platform for open access to molecules and tools exemplifies the transformative power of Open Innovation.

The initiative demonstrated remarkable results, with significant research outputs and global impact, serving as a model for the broader Open Innovation community

CHECK OUT THE REPLAY

Who

Piet Verhoeve

founder Origanius

host

Florian Montel

Head of open science

Boehringer-Ingelheim

Markus Koester

Head of scientific liaison

Boehringer-Ingelheim

FOR WHOM?

Specially designed for Innovators, R&D Professionals and Researchers

that want to go for innovation projects that deliver results

What is opnMe.com ?

opnMe.com, the open innovation portal of Boehringer Ingelheim, aims to accelerate research initiatives to enable new insights of disease biology in areas of high unmet medical need by sharing well-characterized molecules, offer collaborations for science, and postdoc grants. In the spirit of collaboration, the molecules are provided to the scientific community to help unlock and fulfill their full potential. These molecules are either freely available as “Molecules to Order” or applied via scientific research submissions as “Molecules for Collaboration.” The “opn2EXPERTS” program, enlists scientific advice on key biologic issues to fuel further drug discovery and deliver novel solutions that benefit unmet patient needs. This is complemented by “techMATCH” calls which have a more technological focus. The newly launched program, opn2TALENTS, offers defined postdoc grants and awards high-caliber talent that have successfully pitched their scientific ideas and approaches for a well-defined research question. They conduct their research at one of Boehringer’s discovery research sites in Germany, Austria, or the US.